Autonomic modulation by SGLT2i or DPP4i in patients with diabetes favors cardiovascular outcomes as revealed by skin sympathetic nerve activity

BackgroundSodium-glucose cotransporter 2 inhibitors (SGLT2i) and dipeptidyl peptidase-4 inhibitors (DPP4i) are important second-line treatments for patients with type 2 diabetes mellitus (T2DM). Patients taking SGLT2i have favorable cardiovascular outcomes via various mechanisms, including autonomic...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jien-Jiun Chen, Chen Lin, Men-Tzung Lo, Lian-Yu Lin, Hsiang-Chih Chang, Geng-Chi Liu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2024-07-01
Saila:	Frontiers in Pharmacology
Gaiak:	NeuECG skin sympathetic nerve activity autonomic modulation entropy analysis sodium-glucose cotransporter 2 inhibitor
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1424544/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!